최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of enzyme inhibition and medicinal chemistry, v.35 no.1, 2020년, pp.372 - 376
Oh, Youri (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea) , Jang, Miyoung (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea) , Cho, Hyunwook (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea) , Yang, Songyi (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea) , Im, Daseul (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea) , Moon, Hyungwoo (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea) , Hah, Jung-Mi (College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University , Ansan , Korea)
Abstract3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives were designed and synthesised as selective inhibitors of JNK3, a target for the treatment of neurodegenerative diseases. Following previous studies, we have designed JNK3 inhibitors to reduce the molecular weight and successfully identified ...
1 Davis RJ. Signal transduction by the JNK Group of MAP kinases . Cell 2000 ; 103 : 239 ? 52 . 11057897
2 Mishra P , Gunther S. New insights into the structural dynamics of the kinase JNK3 . Sci Rep 2018 ; 8 : 9435 . 29930333
3 Kyriakis JM , Banerjee P , Nikolakaki E , et?al. The stress-activated protein kinase subfamily of c-Jun kinases . Nature 1994 ; 369 : 156 ? 60 . 8177321
4 Bogoyevitch MA , Ngoei KR , Zhao TT , et?al. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges . Biochim Biophys Acta 2010 ; 1804 : 463 ? 75 . 19900593
5 Haeusgen W , Boehm R , Zhao Y , et?al. Specific activities of individual c-Jun N-terminal kinases in the brain . Neuroscience 2009 ; 161 : 951 ? 9 . 19364525
6 Weston CR , Davis RJ. The JNK signal transduction pathway . Curr Opin Cell Biol 2007 ; 19 : 142 ? 9 . 17303404
7 Gupta S , Barrett T , Whitmarsh AJ , et?al. Selective interaction of JNK protein kinase isoforms with transcription factors . Embo J 1996 ; 15 : 2760 ? 70 . 8654373
8 Antoniou X , Falconi M , Di Marino D , Borsello T. JNK3 as a therapeutic target for neurodegenerative diseases . J Alzheimer Dis 2011 ; 24 : 633 ? 42 .
9 Dou X , Huang H , Li Y , et?al. Multistage screening reveals 3-substituted indolin-2-one derivatives as novel and isoform-selective c-Jun N-terminal Kinase 3 (JNK3) inhibitors: implications to drug discovery for potential treatment of neurodegenerative diseases . J Med Chem 2019 ; 62 : 6645 ? 64 . 31268308
10 Koch P , Gehringer M , Laufer SA. Inhibitors of c-Jun N-terminal kinases: an update . J Med Chem 2015 ; 58 : 72 ? 95 . 25415535
11 Flemming A. JNK3 as new target in AD? Nat Rev Drug Discov 2012 ; 11 : 829 . 23123935
12 Kim M , Lee J , Hah JM , et?al. Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1 H -benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects . Bioorg Med Chem 2013 ; 21 : 2271 ? 85 . 23498914
13 Fong CW. Permeability of the blood?brain barrier: molecular mechanism of transport of drugs and physiologically important compounds . J Membr Biol 2015 ; 248 : 651 ? 69 . 25675910
14 Geldenhuys WJ , Mohammad AS , Adkins CE , Lockman PR. Molecular determinants of blood?brain barrier permeation . Ther Deliv 2015 ; 6 : 961 ? 71 . 26305616
15 Tian W , Han G , Zhu J , et?al. Synthesis and acrosin inhibitory activities of 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives . Bioorg Med Chem Lett 2013 ; 23 : 4177 ? 84 . 23746472
16 Gosselin F , O’Shea P , Webster R , et?al. Highly regioselective synthesis of 1-Aryl-3,4,5-substituted pyrazoles . Synlett 2006 ; 2006 : 3267 ? 70 .
17 Ren SZ , Wang ZC , Zhu XH , et?al. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition . Bioorg Med Chem 2018 ; 26 : 4264 ? 75 . 30031652
18 Odell LR , Abdel-Hamid MK , Hill TA , et?al. Pyrimidine-based inhibitors of dynamin I GTPase activity: competitive inhibition at the Pleckstrin Homology domain . J Med Chem 2017 ; 60 : 349 ? 61 . 27997171
19 Beaulieu PL , Bousquet Y , Gauthier J , et?al. Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 Cells . J Med Chem 2004 ; 47 : 6884 ? 92 . 15615537
20 Vivanco I , Palaskas N , Tran C , et?al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN . Cancer Cell 2007 ; 11 : 555 ? 69 . 17560336
21 Szczepankiewicz BG , Kosogof C , Nelson LTJ , et?al. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity . J Med Chem 2006 ; 49 : 3563 ? 80 . 16759099
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.